99 related articles for article (PubMed ID: 12882711)
21. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY
Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of the Chinese traditional medicinal herb Celastrus orbiculatus Thunb on human hepatocellular carcinoma in an orthothopic fluorescent nude mouse model.
Wang M; Zhang X; Xiong X; Yang Z; Sun Y; Yang Z; Hoffman RM; Liu Y
Anticancer Res; 2012 Apr; 32(4):1213-20. PubMed ID: 22493351
[TBL] [Abstract][Full Text] [Related]
23. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
[TBL] [Abstract][Full Text] [Related]
24. [Induction of necrosis in the hepatocellular carcinoma HepG2 xenografts treated with SOM230].
Xie Y; Chen S; Wang CH; Tang CW
Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):759-64. PubMed ID: 19874692
[TBL] [Abstract][Full Text] [Related]
25. [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis].
Li Y; Tang ZY; Wang L; Yao Z; Lu R; Xue Q; Gao DM; Chen J
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):675-9. PubMed ID: 15130313
[TBL] [Abstract][Full Text] [Related]
26. The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.
Gedaly R; Angulo P; Chen C; Creasy KT; Spear BT; Hundley J; Daily MF; Shah M; Evers BM
Anticancer Res; 2012 Jul; 32(7):2531-6. PubMed ID: 22753710
[TBL] [Abstract][Full Text] [Related]
27. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
[TBL] [Abstract][Full Text] [Related]
28. Methylation of Ras association domain family protein 1, isoform A correlated with proliferation and drug resistance in hepatocellular carcinoma cell line SMMC-7721.
Zhao QZ; Dou KF
J Gastroenterol Hepatol; 2007 May; 22(5):683-9. PubMed ID: 17444856
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma.
Venturelli S; Armeanu S; Pathil A; Hsieh CJ; Weiss TS; Vonthein R; Wehrmann M; Gregor M; Lauer UM; Bitzer M
Cancer; 2007 May; 109(10):2132-41. PubMed ID: 17407132
[TBL] [Abstract][Full Text] [Related]
30. [A preliminary study of the inhibitive efficacy of iodized linoleic acid and its fluorodeoxyuridine ester in hepatocellular cancer].
Li KC; Zeng XY; Kuang CX; Jiang YB; Dai ZY
Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):372-5. PubMed ID: 24025140
[TBL] [Abstract][Full Text] [Related]
31. [Inhibitory effects of celecoxib combined with octreotide on growth of multidrug resistant human gastric cancer cell line SGC7901/ADR].
Zheng WB; Wang CH; Qiang O; Tang CW
Ai Zheng; 2004 Dec; 23(12):1628-32. PubMed ID: 15601550
[TBL] [Abstract][Full Text] [Related]
32. Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.
Zhai JM; Yin XY; Lai YR; Hou X; Cai JP; Hao XY; Liang LJ; Zhang LJ
Cancer Chemother Pharmacol; 2013 May; 71(5):1255-64. PubMed ID: 23435877
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma.
Song X; Wang JB; Yin DL; Yang HY; Liu LX; Jiang HC
Chin Med J (Engl); 2009 Nov; 122(21):2636-42. PubMed ID: 19951584
[TBL] [Abstract][Full Text] [Related]
34. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.
Li X; Zhu Y; He H; Lou L; Ye W; Chen Y; Wang J
Biochem Biophys Res Commun; 2013 Jun; 436(2):259-64. PubMed ID: 23726914
[TBL] [Abstract][Full Text] [Related]
35. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line.
Li GC; Ye QH; Xue YH; Sun HJ; Zhou HJ; Ren N; Jia HL; Shi J; Wu JC; Dai C; Dong QZ; Qin LX
Cancer Sci; 2010 Dec; 101(12):2546-53. PubMed ID: 20942864
[TBL] [Abstract][Full Text] [Related]
36. Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
Chen C; Zhang Y; Wang Y; Huang D; Xi Y; Qi Y
Anticancer Drugs; 2011 Jun; 22(5):435-43. PubMed ID: 21502917
[TBL] [Abstract][Full Text] [Related]
37. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
Xiao YS; Zhou J; Tang ZY; Fan J; Wu ZQ; Liu YK; Ye SL; Shen ZZ; Xue Q; Zhao Y
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3205-9. PubMed ID: 16405841
[TBL] [Abstract][Full Text] [Related]
38. Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo.
Hossain MA; Kim DH; Jang JY; Kang YJ; Yoon JH; Moon JO; Chung HY; Kim GY; Choi YH; Copple BL; Kim ND
Int J Oncol; 2012 May; 40(5):1636-42. PubMed ID: 22322725
[TBL] [Abstract][Full Text] [Related]
39. [Chaiqiyigan granula enhances Taxol-induced growth inhibition of hepatocellular carcinoma xenografts in nude mice: an in vivo fluorescence imaging study].
You M; Luo M; Liao W; Hu S; Xu W; Jing L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1042-5. PubMed ID: 22820595
[TBL] [Abstract][Full Text] [Related]
40. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer.
Liang G; Tang A; Lin X; Li L; Zhang S; Huang Z; Tang H; Li QQ
Int J Oncol; 2010 Jul; 37(1):111-23. PubMed ID: 20514403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]